Press release
Services for UKCA marking for Medical
UKCA (United Kingdom Conformity Assessment) marking is a new UK product marking, starting January 1st 2021, that will be used for goods being placed on the market in Great Britain (England, Wales and Scotland). It covers most goods which previously required the CE marking.
For goods being placed on the market in North Ireland the CE regulations remain valid.
For goods being placed on the market in North Ireland the CE regulations remain valid.
DEKRA is in the process of becoming a UK Approved Body (UKAB) for medical device certification (designation by the Medicines and Healthcare Products Regulatory Agency, MHRA).
DEKRA is developing a UKCA service which will be delivered by DEKRA’s newly established legal entity in the UK.
DEKRA is developing a UKCA service which will be delivered by DEKRA’s newly established legal entity in the UK.
From 1 January 2021 to 1 July 2023 CE marking will still be recognized by the UK for medical products. As of July 2023 however, manufacturers who wish to (continue to) place their products on the UK market need to comply with the new UKCA marking regulation.DEKRA will be able to support its customers with these new services after designation by UKAS and the Medicines and Healthcare Products Regulatory Agency (MHRA).
For more details, please contact us.